FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hiroyuki Sugahara

Research Profile

Chemicals & Drugs

Physiology

Living Beings

Mouse

Anatomy

Co-author Network

Publications

TOP 3
Hiroyuki Murota; Yukiko Shoda; Tomohiko Ishibashi; Hiroyuki Sugahara; Itaru Matsumura; Ichiro Katayama
Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy.
Mitsuaki Tatsumi; Hiroyuki Sugahara; Ichiro Higuchi; Hiroki Fukunaga; Hironobu Nakamura; Yuzuru Kanakura; Jun Hatazawa
Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values.
Jun Ishiko; Masao Mizuki; Itaru Matsumura; Hirohiko Shibayama; Hiroyuki Sugahara; Glen Scholz; Hubert Serve; Yuzuru Kanakura
Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hiroyuki Sugahara (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Hiroyuki Murota; Yukiko Shoda; Tomohiko Ishibashi; Hiroyuki Sugahara; Itaru Matsumura; Ichiro Katayama
Improvement of recurrent urticaria in a patient with Schnitzler syndrome associated with B-cell lymphoma with combination rituximab and radiotherapy.
Journal of the American Academy of Dermatology 2009;61(6):1070-5.
2009: Mitsuaki Tatsumi; Hiroyuki Sugahara; Ichiro Higuchi; Hiroki Fukunaga; Hironobu Nakamura; Yuzuru Kanakura; Jun Hatazawa
Standardized uptake value on FDG-PET as a marker for disease activity in patients with non-Hodgkin's lymphoma: comparison with serum soluble interleukin-2 receptor values.
International journal of clinical oncology 2009;14(2):150-8.
2005: Jun Ishiko; Masao Mizuki; Itaru Matsumura; Hirohiko Shibayama; Hiroyuki Sugahara; Glen Scholz; Hubert Serve; Yuzuru Kanakura
Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant.
Oncogene 2005;24(55):8144-53.
2004: Yusuke Satoh; Itaru Matsumura; Hirokazu Tanaka; Sachiko Ezoe; Hiroyuki Sugahara; Masao Mizuki; Hirohiko Shibayama; Eri Ishiko; Jun Ishiko; Koichi Nakajima; Yuzuru Kanakura
Roles for c-Myc in self-renewal of hematopoietic stem cells.
The Journal of biological chemistry 2004;279(24):24986-93.
2004: Hiroyuki Sugahara; Masao Mizuki; Sayoko Matsumae; Yoshiko Nabetani; Motoko Kikuchi; Yuzuru Kanakura
Footwear exchange has no influence on the incidence of febrile neutropenia in patients undergoing chemotherapy for hematologic malignancies.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(1):51-4.
2003: Xian Zhang; Takashi Machii; Itaru Matsumura; Sachiko Ezoe; Akira Kawasaki; Hirokazu Tanaka; Shuji Ueda; Hiroyuki Sugahara; Hirohiko Shibayama; Masao Mizuki; Yuzuru Kanakura
Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.
International journal of hematology 2003;77(3):263-73.
2003: Koji Hashimoto; Itaru Matsumura; Tohru Tsujimura; Dae-Ki Kim; Hideki Ogihara; Hirokazu Ikeda; Shuji Ueda; Masao Mizuki; Hiroyuki Sugahara; Hirohiko Shibayama; Yukihiko Kitamura; Yuzuru Kanakura
Necessity of tyrosine 719 and phosphatidylinositol 3'-kinase-mediated signal pathway in constitutive activation and oncogenic potential of c-kit receptor tyrosine kinase with the Asp814Val mutation.
Blood 2003;101(3):1094-102.
2002: Shuji Ueda; Hirokazu Ikeda; Masao Mizuki; Jun Ishiko; Itaru Matsumura; Hirokazu Tanaka; Hirohiko Shibayama; Hiroyuki Sugahara; Emi Takai; Xian Zhang; Takashi Machii; Yuzuru Kanakura
Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296.
International journal of hematology 2002;76(5):427-35.
2002: Shuji Ueda; Masao Mizuki; Hirokazu Ikeda; Tohru Tsujimura; Itaru Matsumura; Kazushi Nakano; Hanako Daino; Zen-ichiro Honda Zi; Junko Sonoyama; Hirohiko Shibayama; Hiroyuki Sugahara; Takashi Machii; Yuzuru Kanakura
Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration.
Blood 2002;99(9):3342-9.
2001: M Tatsumi; H Kitayama; Hiroyuki Sugahara; N Tokita; H Nakamura; Yuzuru Kanakura; Tsunehiko Nishimura
Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(4):601-8.
1999: Tohru Tsujimura; Keiko Hashimoto; H Kitayama; Hirokazu Ikeda; Hiroyuki Sugahara; Itaru Matsumura; Tsuneyasu Kaisho; N Terada; Yukihiko Kitamura; Yuzuru Kanakura
Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.
Blood 1999;93(4):1319-29.
1998: Itaru Matsumura; Koichi Nakajima; Hiroshi Wakao; S Hattori; Keiko Hashimoto; Hiroyuki Sugahara; Takayuki Kato; H Miyazaki; T Hirano; Yuzuru Kanakura
Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
Molecular and cellular biology 1998;18(7):4282-90.
1998: Takashi Yokota; Kenji Oritani; H Mitsui; K Aoyama; Jun Ishikawa; Hiroyuki Sugahara; Itaru Matsumura; Schickwann Tsai; Yoshiaki Tomiyama; Yuzuru Kanakura; Yuji Matsuzawa
Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: structural requirement for fibronectin activities of CS1 and cell-binding domains.
Blood 1998;91(9):3263-72.
1995: H Kitayama; Yuzuru Kanakura; T Furitsu; T Tsujimura; Kenji Oritani; H Ikeda; Hiroyuki Sugahara; H Mitsui; Y Kanayama; Y Kitamura
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
Blood 1995;85(3):790-8.
1994: Hiroyuki Sugahara; Yuzuru Kanakura; T Furitsu; K Ishihara; Kenji Oritani; H Ikeda; H Kitayama; Jun Ishikawa; Keiko Hashimoto; Y Kanayama
Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.
The Journal of experimental medicine 1994;179(6):1757-66.
1993: H Ikeda; Yuzuru Kanakura; T Furitsu; H Kitayama; Hiroyuki Sugahara; Tetsuo Nishiura; T Karasuno; Yoshiaki Tomiyama; Atsushi Yamatodani; Y Kanayama
Changes in phenotype and proliferative potential of human acute myeloblastic leukemia cells in culture with stem cell factor.
Experimental hematology 1993;21(13):1686-94.
1993: T Furitsu; T Tsujimura; T Tono; H Ikeda; H Kitayama; Uichi Koshimizu; Hiroyuki Sugahara; J H Butterfield; L K Ashman; Y Kanayama
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
The Journal of clinical investigation 1993;92(4):1736-44.
1993: Yuzuru Kanakura; H Ikeda; H Kitayama; Hiroyuki Sugahara; T Furitsu
Expression, function and activation of the proto-oncogene c-kit product in human leukemia cells.
Leukemia & lymphoma 1993;10(1-2):35-41.
1993: Yuzuru Kanakura; Hiroyuki Sugahara; H Mitsui; H Ikeda; T Furitsu; H Yagura; H Kitayama; Y Kanayama; Yuji Matsuzawa
Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor.
Cancer research 1993;53(3):675-80.